XML 84 R69.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Schedule of Stock Awards) (Details) - Performance Stock Units - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Number of Shares      
Balance at beginning of the period (in shares) 207,279 162,381 149,961
Granted (in shares) 108,096 140,953 91,988
Dividend equivalents (in shares) 9,198 7,236 6,210
Forfeited (in shares)   (3,245) (4,840)
Vested (in shares) (78,695) (100,046) (80,938)
Balance at end of the period (in shares) 245,878 207,279 162,381
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Outstanding exercise price (in usd per share) $ 122.57 $ 120.12 $ 104.01
Granted (in usd per share) 132.77 108.42 110.83
Dividend equivalents (in usd per share) 112.27 117.20 103.29
Forfeited (in usd per share)   96.55 78.11
Vested (in usd per share) 143.54 101.11 82.40
Outstanding exercise price (in usd per share) $ 120.26 $ 122.57 $ 120.12